Biotech News - Page 4
Veterinary Internal Medicine
December 10, 2012
The term 'internal medicine' has German origins and the concept clubs together patient care with science of the laboratory, while geriatric medicine is its underlying branch that deals with healthcare for the elderly.
December 10, 2012
The term 'internal medicine' has German origins and the concept clubs together patient care with science of the laboratory, while geriatric medicine is its underlying branch that deals with healthcare for the elderly.
Botany Products
December 7, 2012
Botany products include herbs micro-plants, and many related pharmaceutical products, and find application and close correlation with many other pharmaceutical products and their usage.
December 7, 2012
Botany products include herbs micro-plants, and many related pharmaceutical products, and find application and close correlation with many other pharmaceutical products and their usage.
Government Initiatives to Support the Indian Bioinformatics Growth
December 4, 2012
The Department of Biotechnology (DBT) of the Ministry of Science and Technology, Government of India has been playing a pivotal role in promoting the market, says RNCOS.
December 4, 2012
The Department of Biotechnology (DBT) of the Ministry of Science and Technology, Government of India has been playing a pivotal role in promoting the market, says RNCOS.
IMARC Group Releases the Most Comprehensive Report on the Global Biopharmaceutical Market
November 27, 2012
Driven by their target oriented nature that enables them to attack only the diseased cells without affecting the healthy ones, biopharmaceuticals today represent one of the fastest growing segments of the pharmaceutical industry.
November 27, 2012
Driven by their target oriented nature that enables them to attack only the diseased cells without affecting the healthy ones, biopharmaceuticals today represent one of the fastest growing segments of the pharmaceutical industry.
Key Competitors Riding on Core Biotech Strengths
November 22, 2012
Key competitors are riding on their core biotech strengths and expanding their biotech API capabilities, says RNCOS in its latest research report.
November 22, 2012
Key competitors are riding on their core biotech strengths and expanding their biotech API capabilities, says RNCOS in its latest research report.
Significant Potential for Growth Underlines Therapeutic Cancer Vaccines
November 12, 2012
Therapeutics cancer vaccine market in the US poses significant potential for growth and evolution, says RNCOS.
November 12, 2012
Therapeutics cancer vaccine market in the US poses significant potential for growth and evolution, says RNCOS.
Rising Awareness to Drive Global Genetic Testing Market
November 2, 2012
Rising awareness and greater acceptance among people will drive the global genetic testing market, says RNCOS.
November 2, 2012
Rising awareness and greater acceptance among people will drive the global genetic testing market, says RNCOS.
Challenges Abound the US Personalized Cancer Genome Sequencing Market
November 2, 2012
Factors like high costs, high turnaround time, low penetration and poor awareness amongst physicians and patients are holding back the huge multimillion dollar market, says RNCOS.
November 2, 2012
Factors like high costs, high turnaround time, low penetration and poor awareness amongst physicians and patients are holding back the huge multimillion dollar market, says RNCOS.
Global Biopharmaceutical Market to Exceed USD 166 Billion by 2017
November 1, 2012
Driven by their high potency and ability to attack targets beyond the reach of traditional small molecule drugs, the global biopharmaceutical market is expected to exceed sales worth USD 166 Billion by 2017.
November 1, 2012
Driven by their high potency and ability to attack targets beyond the reach of traditional small molecule drugs, the global biopharmaceutical market is expected to exceed sales worth USD 166 Billion by 2017.
Global Biopharmaceutical Market to Exceed USD 166 Billion by 2017
October 30, 2012
Driven by their high potency and ability to attack targets beyond the reach of traditional small molecule drugs, the global biopharmaceutical market is expected to exceed sales worth USD 166 Billion by 2017.
October 30, 2012
Driven by their high potency and ability to attack targets beyond the reach of traditional small molecule drugs, the global biopharmaceutical market is expected to exceed sales worth USD 166 Billion by 2017.